Business
EU’s drug regulator backs AstraZeneca vaccine after safety investigation – Sydney Morning Herald
The regulator said the vaccine did not increase the overall risk of blood clots but cannot rule out a link with two very rare blood disorders.
This pandemic is costing lives. We have vaccines that are safe and effective and can prevent deaths and hospitalisations. We need to use those vaccines.
The countries had been under pressure to urgently restart the AstraZeneca rollout following the EMAs conclusions.
Working with data from other agencies around the world, the EMA found the number of thromboembolic events reported during trials and the broader rollout was 469 lower than what would normally be expected in the general population.
Sabine…
-
General20 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business19 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General21 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General23 hours agoAlbanese beats drum on economy as trade clouds gather